Business
Why the Immuron (ASX:IMC) share price is rocketing up 10% today
The Immuron Ltd (ASX: IMC) share price is surging today following a research agreement with Monash University for combating COVID-19. At the time of writing, the Immuron share price is up 10.42% to 26.5 cents.
Immuron is clinical-stage biopharmaceutical company focused on the development and commercialisation of a novel class of specifically targeted polyclonal antibodies. The company researches and develops hyperimmune products for markets in Australia, the United States and Canada.
Product sales comprise Travelan and Protectyn, which is used for the prevention of travellers’ diarrhoea.
What’s pushing the Immuron share price higher?
The Immuron share price has been a positive mover today compared to the broader All Ordinaries…
-
Noosa News22 hours agoMan shot by police outside Wynnum West house fire charged with attempted murder and arson
-
Noosa News19 hours agoBrisbane man charged with arson and attempted murder after violent house fire at Wynnum West
-
Business23 hours agoGuess which dirt cheap ASX 200 stock could rise 50%+
-
Business22 hours agoWhy these brokers are very bullish on this ASX bank share